z-logo
open-access-imgOpen Access
Lipid Mediators and Human Leukemic Blasts
Author(s) -
Rémi Fiancette,
Christelle VincentFabert,
Estelle Guérin,
Franck Trimoreau,
Yves Denizot
Publication year - 2010
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2011/389021
Subject(s) - lipid signaling , apoptosis , phospholipase a2 , receptor , phospholipase , medicine , leukotriene , microbiology and biotechnology , cell growth , inflammation , mediator , platelet activating factor , cancer research , enzyme , immunology , biology , biochemistry , asthma
Some of the most potent inflammatory mediators share a lipid origin. They regulate a wide spectrum of cellular processes including cell proliferation and apoptosis. However, the precise roles and ways (if any) in which these compounds impact the growth and apoptosis of leukemic blasts remain incompletely resolved. In spite of this, significant advances have been recently made. Here we briefly review the current knowledge about the production of lipid mediators (prostaglandins, leukotrienes, platelet-activating factor) by leukemic blasts, the enzymatic activities (phospholipase A(2), cyclooxygenases, lipoxygenases) involved in their productions and their effects (through specific membrane bound receptors) on the growth, and apoptosis of leukemic blasts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom